Indication
Active immunisation against invasive disease caused by Neisseria meningitidis serogroup-B strains.
Loading your page…
Loading your page…
Meningitis, Meningococcal
Marketing Authorisation Holder: GSK Vaccines S.r.l.
EMA Authorisation: 13/01/2013
INN: meningococcal group B Vaccine (rDNA, component, adsorbed)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Bexsero: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.